Rankings
▼
Calendar
CTKB Q4 2025 Earnings — Cytek Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
CTKB
Cytek Biosciences, Inc.
$553M
Q4 2025 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$62M
+8.1% YoY
Gross Profit
$33M
52.9% margin
Operating Income
-$6M
-9.0% margin
Net Income
-$44M
-70.9% margin
EPS (Diluted)
$-0.34
QoQ Revenue Growth
+18.8%
Cash Flow
Operating Cash Flow
-$771,000
Free Cash Flow
-$2M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$462M
Total Liabilities
$120M
Stockholders' Equity
$342M
Cash & Equivalents
$91M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$62M
$57M
+8.1%
Gross Profit
$33M
$34M
-2.3%
Operating Income
-$6M
$3M
-287.3%
Net Income
-$44M
$10M
-557.1%
Revenue Segments
Product
$47M
100%
Geographic Segments
UNITED STATES
$26M
41%
EMEA
$20M
32%
Asia Pacific
$13M
21%
Other
$4M
6%
← FY 2025
All Quarters